Latest Articles

Publication Date
Short-course radiation therapy proves effective for treating endometrial cancer - @theU

Short-course radiation therapy proves effective for treating endometrial cancer @theU

Published: Feb. 19, 2025, 6:50 p.m.
A Fibronectin (FN)-Silk 3D Cell Culture Model as a Screening Tool for Repurposed Antifibrotic Drug Candidates for Endometriosis.

This study advances sustainable pharmaceutical research for endometriosis by developing in vitro 3D cell culture models of endometriotic pathophysiology that allow antifibrotic drug candidates to be tested. Fibrosis is a …

Published: Feb. 19, 2025, midnight
Endometriosis in Adolescents: A Closer Look at the Pain Characteristics and Atypical Symptoms: A Prospective Cohort Study.

Background/Objectives: Endometriosis affects up to 10% of women of reproductive age and about 47% of adolescents with pelvic pain. Symptoms include dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Adolescents often …

Published: Feb. 19, 2025, midnight
Reprogramming peritoneal macrophages with outer membrane vesicle-coated PLGA nanoparticles for endometriosis prevention.

Endometriosis is a chronic inflammatory disease that primarily affects women of reproductive age. The current hormonal treatments are unsuitable for women who wish to conceive, highlighting the need for non-hormonal …

Published: Feb. 17, 2025, midnight
Short-course radiation matches standard therapy for endometrial cancer - MSN

Short-course radiation matches standard therapy for endometrial cancer MSN

Published: Feb. 16, 2025, 9:30 a.m.
External ureteral involvement as a result of ovarian cancer initially suspected as endometriosis leading to the diagnosis of squamous cell carcinoma.

Ovarian squamous cell carcinoma [SCC] is a rare and aggressive malignancy that can mimic benign gynecological disorders, often leading to diagnostic delays and suboptimal management. Ureteral obstruction and subsequent hydroureteronephrosis …

Published: Feb. 15, 2025, midnight
Bladder Endometriosis: Diagnostic, Therapy, and Outcome of a Single-Center Experience.

Background/Objectives: Endometriosis is a benign condition affecting up to 10% of women at reproductive age. The urinary tract is affected in 0.3-12.0% of women with endometriosis and in 19.0-53.0% of …

Published: Feb. 14, 2025, midnight
Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer - OncLive

Dr Wagar on the Role of Adjuvant Immunotherapy in Endometrial Cancer OncLive

Published: Feb. 13, 2025, 8:12 p.m.
Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug - Forbes

Gesynta Pharma Receives $27 M For Endometriosis Novel Therapy Drug Forbes

Published: Feb. 13, 2025, 5:04 p.m.
Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug - Forbes

Gesynta Pharma Receives $27 Million For Endometriosis Novel Therapy Drug Forbes

Published: Feb. 13, 2025, 5:04 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!